diaDexus, Inc. Product Pipeline Analysis

SUMMARY

diaDexus, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a diaDexus, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Financial Performance 7
2.3 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 Feb 19, 2008: diaDexus Receives FDA Clearance For Automated Blood Test That Identifies Stroke & Heart Attack Risk 12
7.2 Product Approvals 12
7.2.1 Feb 19, 2008: diaDexus Receives FDA Clearance For Automated Blood Test That Identifies Stroke & Heart Attack Risk 12
8 diaDexus, Inc. Pipeline Products 13
8.1 diaDexus, Inc. Product Pipeline Analysis 13
8.1.1 diaDexus, Inc. Pipeline Products By Equipment Type 13
8.1.2 diaDexus, Inc. Pipeline Products By Development Stage 14
8.1.3 diaDexus, Inc. Pipeline Products By Therapy Area 15
8.2 B7-H4 (DD-O110) 15
8.2.1 Product Description 15
8.2.2 Product Status 15
8.3 Spondin-2 (DD-P108) 15
8.3.1 Product Description 16
8.3.2 Product Status 16
8.4 DcR3 (DD-C248) 16
8.4.1 Product Description 16
8.4.2 Product Status 16
8.5 MIC-1 (DD-X065) 17
8.5.1 Product Description 17
8.5.2 Product Status 17
8.6 Reg IV (DD-C101) 17
8.6.1 Product Description 17
8.6.2 Product Status 18
8.7 TRAIL-R2 18
8.7.1 Product Description 18
8.7.2 Product Status 18
9 Appendix 19
9.1 Methodology 19
9.1.1 Coverage 19
9.1.2 Secondary Research 20
9.1.3 Primary Research 20
9.1.4 Expert Panel Validation 21
9.2 Contact Us 21
9.3 About Global Markets Direct 21
9.4 Disclaimer 21

1.1 List Of Tables
Table 1: diaDexus, Inc.,Key Facts 7
Table 2: diaDexus, Inc., Key Employees, 10
Table 3: diaDexus, Inc. Pipeline Products by Equipment Type 13
Table 4: diaDexus, Inc. Pipeline Products By Development Stage 14
Table 5: diaDexus, Inc. Pipeline Products By Therapy Area 15

1.2 List of Figures
Figure 1: diaDexus, Inc. Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 19